In this study, it was revealed that the therapeutic effects of TSD on VaD are mostly attributed to the potential core targets of AKT1, CASP3, IL1β, JUN, and TP53, which are associated with cell apoptosis and inflammatory. This evidence concerns the gene AKT1 and Tay-Sachs disease.